Zika virus drug 'induces robust and durable immune responses' against virus

Zika virus drug 'induces robust and durable immune responses' against virus The drug, which is being developed by the firm Inovio, showed encouraging results in mice. it will now be tested in non-human primates before the first human trials begin before the end of this year.